Cambridge Investment Research Advisors’s Stantec STN Stock Holding History
Bought
Maintained
Sold
Other funds holding STN
Cambridge Investment Research Advisors's STN Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Stantec (STN) stake by 4.8% in Q2 2026, selling an estimated $26K and leaving 6,321 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #3094.
Cambridge Investment Research Advisors first reported a position in STN in Q4 2021 and has held it in 19 quarters since. The position peaked at $687K in Q3 2025. 292 funds tracked by Wall St. Rank hold STN as of Q2 2026.
- Cambridge Investment Research Advisors held 6,321 shares of Stantec worth $436K as of Q2 2026.
- Cambridge Investment Research Advisors sold 322 Stantec shares in Q2 2026, an estimated $26K.
- Stantec made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3094 holding.
- Cambridge Investment Research Advisors first reported a position in Stantec in Q4 2021 and has held it in 19 quarters since.
- Cambridge Investment Research Advisors's Stantec position peaked at $687K in Q3 2025.
- 292 funds tracked by Wall St. Rank held Stantec as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.